Substance use treatment provider Pinnacle Treatment Centers could be up for sale, according to Axios Pro.
Linden Capital Partners, a Chicago-based private equity fund, acquired its controlling stake in Pinnacle in August 2016. Axios reports that Linden Capital retained Lincoln International to oversee the sale of Pinnacle Treatment Centers.
Founded in 2016, the Mt. Laurel, New Jersey-based addiction treatment provider expanded into a ninth state market earlier in the month with the acquisition of Stepping Stone of North Carolina. Pinnacle Treatment Centers operates 130 locations in California, Georgia, Indiana, Kentucky, New Jersey, Ohio, Pennsylvania, Virginia, and now North Carolina.
The Stepping Stones deal marks 31% growth in the company’s facility count in a little over two years.
Axios reports that Pinnacle’s EBITDA could be between $70 million to $75 million by the end of the year.
Representatives of Pinnacle Treatment Centers and Linden Capital Partners have not responded to a request for comment.
Pinnacle’s CEO told Behavioral Health Business that the company’s growth strategy focuses on serving Medicaid enrollees and using state partners to lead it to areas of need and opportunity. It then uses operational savvy to provide care while getting paid the comparatively low rates that Medicaid programs typically afford addiction treatment.
“The disease is the same; some of the environmental factors might be different [and] how services can be deployed,” Pritchard said of patients with different financing for their health care options.
Companies featured in this article:
